MedPath

Effects of Macular Buckle Versus Vitrectomy on Macular Schisis and Macular Detachment in Highly Myopic Eyes

Not Applicable
Completed
Conditions
Macular Detachment
Retinoschisis
High Myopia
Registration Number
NCT03023800
Lead Sponsor
Sun Yat-sen University
Brief Summary

Macular schisis associated with macular detachment is a one of the complications of high myopia. There is controversy in the primary treatment for this situation. This study will compare the effects of macular buckling + gas injection versus vitrectomy + internal limiting membrane peeling + gas tamponade in a cohort of highly myopic eyes with macular retinal detachment associated with macular schisis.

Detailed Description

A randomized, open label, single center study comparing the efficacy of macular muckle + gas injection versus internal limiting membrane peeling + gas tamponade on macular schisis associated with macular detachment in eyes with high myopia.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • axial length ≥ 26.5 mm or refractive error (spherical equivalent) ≥ 8.0 diopter
  • macular schisis
  • macular retinal detachment
  • evidence of posterior staphyloma on clinical examination
Exclusion Criteria
  • severe macular scar
  • macular detachment which extended to the peripheral retina (i.e., extension beyond the major vascular arcades in more than one quadrant)
  • prominent vitreomacular traction
  • a history of vitrectomy or macular buckle
  • intraocular active hemorrhage or inflammation
  • any media opacity which precluded imaging or clinical evaluation of the macula

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Retinal re-attachment rate3 month
Secondary Outcome Measures
NameTimeMethod
Post-operative best corrected visual acuity12 month
Post-operative macular structure on optical coherance tomography12 month

Trial Locations

Locations (1)

Zhongshan Ophthalmic Center

🇨🇳

Guangzhou, Guangdong, China

Zhongshan Ophthalmic Center
🇨🇳Guangzhou, Guangdong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.